Literature DB >> 26155779

Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.

Stefano Realdon1, Alessandro Antonello2, Diletta Arcidiacono3,4, Elisa Dassie3, Francesco Cavallin5, Matteo Fassan6, Maria Teresa Nardi7, Alfredo Alberti3,8, Massimo Rugge6, Giorgio Battaglia2.   

Abstract

PURPOSE: While adherence to the World Cancer Research Fund (WCRF) guidelines on lifestyle and cancer was recently proven to be associated with an increased risk of esophageal cancer, no investigation has yet been carried out on its role on Barrett's esophagus (BE) development and its progression to esophageal adenocarcinoma (EAC). The primary aim of this study was to evaluate the role of adherence to WCRF lifestyle recommendations in BE onset and progression. The secondary aim was to investigate the association between disease progression and specific aspects of diet and lifestyle.
METHODS: Established risk factors for BE and EAC development and adherence to WCRF guidelines were assessed in 107 consecutive patients undergoing an upper gastrointestinal endoscopy for symptoms suggesting gastroesophageal reflux (GERD) and a suspected diagnosis of BE/dysplasia on BE. Patients were divided according to histology: those with GERD without metaplasia, with non-dysplastic BE, with low-grade dysplasia, with high-grade dysplasia or with early EAC. The four groups were expressed as an ordered categorical variable of disease progression. An ordered logit model was estimated to identify the independent predictors of disease progression.
RESULTS: Adherence to WCRF guidelines was identified as independent protective factor (OR 0.51, 95 % CI 0.37-0.67) of disease progression. Disease progression was associated with reduced adherence to guidelines on physical activity (from 48.2 to 5.3 %, p = 0.001), sedentary habits (from 33.3 to 0 %, p = 0.03), fruit consumption (from 37.0 to 5.6 %, p = 0.02) and processed meat consumption (from 51.9 to 10.5 %, p = 0.002).
CONCLUSION: Adherence to WCRF guidelines has a protective factor in BE onset and its evolution to EAC.

Entities:  

Keywords:  Barrett’s esophagus; Diet; Esophageal adenocarcinoma; Lifestyle

Mesh:

Year:  2015        PMID: 26155779     DOI: 10.1007/s00394-015-0975-1

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  58 in total

1.  Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus.

Authors:  L Jiao; J R Kramer; L Chen; M Rugge; P Parente; G Verstovsek; A Alsarraj; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

Review 2.  Physical and immunological aspects of exercise in chronic diseases.

Authors:  Vasso Apostolopoulos; Erika Borkoles; Remco Polman; Lily Stojanovska
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

3.  Reliability of meat, fish, dairy, and egg intake over a 33-year interval in Adventist Health Study 2.

Authors:  Pramil N Singh; Michael Batech; Pegah Faed; Karen Jaceldo-Siegl; Marcia Martins; Gary E Fraser
Journal:  Nutr Cancer       Date:  2014-10-08       Impact factor: 2.900

4.  Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008).

Authors:  Nour Makarem; Yong Lin; Elisa V Bandera; Paul F Jacques; Niyati Parekh
Journal:  Cancer Causes Control       Date:  2015-01-06       Impact factor: 2.506

5.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

6.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 7.  Physical activity and risk of gastric cancer: a meta-analysis of observational studies.

Authors:  Ajibola Ibraheem Abioye; Majeed Olaniyi Odesanya; Asanat Iyabode Abioye; Nasiru Akanmu Ibrahim
Journal:  Br J Sports Med       Date:  2014-01-16       Impact factor: 13.800

8.  The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.

Authors:  A P Thrift; D C Whiteman
Journal:  Ann Oncol       Date:  2012-07-30       Impact factor: 32.976

Review 9.  Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Br J Nutr       Date:  2013-11-13       Impact factor: 3.718

10.  Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study.

Authors:  Maryam S Farvid; Eunyoung Cho; Wendy Y Chen; A Heather Eliassen; Walter C Willett
Journal:  BMJ       Date:  2014-06-10
View more
  4 in total

Review 1.  Precision care for Barrett's esophagus.

Authors:  George Triadafilopoulos; Shai Friedland
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-17

2.  The Design, Development and Evaluation of the Vegetarian Lifestyle Index on Dietary Patterns among Vegetarians and Non-Vegetarians.

Authors:  Lap T Le; Joan Sabaté; Pramil N Singh; Karen Jaceldo-Siegl
Journal:  Nutrients       Date:  2018-04-26       Impact factor: 5.717

Review 3.  Improving Patient Adherence to Lifestyle Changes for the Management of Gastroesophageal Reflux.

Authors:  Livia Guadagnoli; Madison Simons; Josie McGarva; Tiffany H Taft; Miranda A L van Tilburg
Journal:  Patient Prefer Adherence       Date:  2022-04-05       Impact factor: 2.711

4.  A phase I pilot study evaluating the beneficial effects of black raspberries in patients with Barrett's esophagus.

Authors:  Laura A Kresty; John J Fromkes; Wendy L Frankel; Cynthia D Hammond; Navindra P Seeram; Maureen Baird; Gary D Stoner
Journal:  Oncotarget       Date:  2016-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.